Synbio Tech

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Synbio Tech - overview

Established

2013

Location

Suzhou, Jiangsu, China

Primary Industry

Biotechnology

About

Based in Suzhou, China and established in 2013, Synbio Tech operates as a DNA synthesis biotechnology company.


Current Investors

Sharelink Capital, Co-Win Ventures, Shenzhen Huada Gene Technology Co., Ltd.

Primary Industry

Biotechnology

Sub Industries

Molecular Science, Genetics & Gene Therapy

Website

www.synbio-tech.com.cn

Company Stage

Series B

Total Amount Raised

Subscriber access only

Synbio Tech - financials

Fiscal Year EndedDec 31, 2015Dec 31, 2016Dec 31, 2017Dec 31, 2018
Revenue (USD)14,097,295.6---
% Revenue Growth (YoY)----
EBITDA (USD)(903,027.8)---
Operating Income (USD)(2,027,580.2)---
Operating Margin(14.4%)---
% EBITDA Margin(6.4%)---
NET Income (USD)(1,084,822.3)---
% Net Margin(7.7%)---

Synbio Tech - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Series BCompletedSynbio Tech-
Series ACompletedSynbio Tech-

Displaying 1 - 2 of 2

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.